1. KalVista Shares Surge as Italian Pharma Group Chiesi Secures $1.9 Billion Acquisition Deal
KalVista Pharmaceuticals saw its shares climb sharply after the company entered into a definitive agreement to be acquired by Chiesi, the Italy-based global pharmaceutical group, in a transaction valued at approximately $1.9 billion. The deal signals a notable consolidation move in the biotech sector, with KalVista sha...